Interrogating the enhancer landscape of intracranial ependymomas: perspectives for precision medicine

Konstantin OkonechnikovHopp-Children’s Cancer Center at the NCT Heidelberg (KiTZ), Heidelberg, Germany;Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, GermanyView further author information

Stephen C. MackDepartment of Pediatrics, Baylor College of Medicine, Houston, TX, USAView further author information

Marcel KoolHopp-Children’s Cancer Center at the NCT Heidelberg (KiTZ), Heidelberg, Germany;Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, GermanyView further author information

Stefan M. PfisterHopp-Children’s Cancer Center at the NCT Heidelberg (KiTZ), Heidelberg, Germany;Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany;Department of Pediatric Hematology and Oncology, Heidelberg University Hospital, Heidelberg, GermanyView further author information

Kristian W. PajtlerHopp-Children’s Cancer Center at the NCT Heidelberg (KiTZ), Heidelberg, Germany;Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany;Department of Pediatric Hematology and Oncology, Heidelberg University Hospital, Heidelberg, GermanyCorrespondence[email protected]
View further author information

Click to increase image sizeClick to decrease image size

Declaration of interest

K Okonechnikov, KW Pajtler, M Kool and SM Pfister were supported by Hopp-Children’s Cancer Center at the NCT Heidelberg (KiTZ), Heidelberg, Germany; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany. SC Mack was supported by the Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. Peer reviewers on this manuscript have no relevant financial or other relationships to disclose.

Additional information

Funding

This article was funded by Hopp-Children’s Cancer Center at the NCT Heidelberg (KiTZ), German Cancer Research Center (DKFZ).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Interrogating the enhancer landscape of intracranial ependymomas: perspectives for precision medicine

Information for

Open access

Opportunities

Help and information

Interrogating the enhancer landscape of intracranial ependymomas: perspectives for precision medicine

Declaration of interest

Additional information

Funding

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature